Foxo3 Promotes Apoptosis of B Cell Receptor–Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing

Abstract

Central tolerance checkpoints are critical for the elimination of autoreactive B cells and the prevention of autoimmunity. When autoreactive B cells encounter their Ag at the immature B cell stage, BCR cross-linking induces receptor editing, followed by apoptosis if edited cells remain autoreactive. Although the transcription factor Foxo1 is known to promote receptor editing, the role of the related factor Foxo3 in central B cell tolerance is poorly understood. We find that BCR-stimulated immature B cells from Foxo3-deficient mice demonstrate reduced apoptosis compared with wild type cells. Despite this, Foxo3 mice do not develop increased autoantibodies. This suggests that the increased survival of Foxo3 immature B cells allows additional rounds of receptor editing, resulting in more cells "redeeming" themselves by becoming nonautoreactive. Indeed, increased Igλ usage and increased recombining sequence recombination among Igλ-expressing cells were observed in Foxo3 mice, indicative of increased receptor editing. We also observed that deletion of high-affinity autoreactive cells was intact in the absence of Foxo3 in the anti-hen egg lysozyme (HEL)/membrane-bound HEL model. However, Foxo3 levels in B cells from systemic lupus erythematosus (SLE) patients were inversely correlated with disease activity and reduced in patients with elevated anti-dsDNA Abs. Although this is likely due in part to increased B cell activation in these SLE patients, it is also possible that low-affinity B cells that remain autoreactive after editing may survive inappropriately in the absence of Foxo3 and become activated to secrete autoantibodies in the context of other SLE-associated defects.

PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155

“…25 FOXO3 was reportedly able to promote the proliferation of T lymphocytes and B lymphocytes. 26,27 However, in this study, we have not conducted in vivo cell experiments to verify it in future studies.…”

Increased B Cell Understanding Puts Improved Vaccine Platforms Just Over the Horizon

“…B cells’ ability to enter the GC and differentiate into an effector cell is mediated by their activation by Ag via the BCR, though a basal or tonic BCR signal is also necessary for continued cell survival and maturation ( 19 ). In the first day following immunization, activated B cells which have bound their cognate Ag migrate to the interfollicular zone in the lymph node, guided by increased expression of GPCR receptor EBI2 ( 20 ), where they have higher chances of encountering cognate Ag.…”

RNA Methylation in Systemic Lupus Erythematosus

“…As an important transcription factor, FOXO1 promotes the expression of VCAM-1 and ICAM-1 by directly binding to their promoter regions, which leads to endothelial inflammation and atherosclerosis development ( Jian et al, 2020 ). The FOXO3 levels in B cells from patients with SLE are inversely correlated with disease activity and reduced in patients with elevated anti-dsDNA Ab levels ( Ottens et al, 2018 ).…”